DNA mismatch repair deficiency tumour testing for patients with colorectal cancer Recommendations
Colorectal cancer (CRC) is the third most common cancer in men and the second in women worldwide. Approximately 3% to 5% of colorectal cancers are attributable to a hereditary cancer predisposition related to DNA mismatch repair (MMR) deficiency. Deficient MMR (dMMR) results in an inability to corre...
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Ottawa, Ontario :
Canadian Agency for Drugs and Technologies in Health
2016.
|
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009820280706719 |
